QNCX
Closed
Cortexyme Inc
1.52
-0.13 (-7.88%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.65
Day's Range: 1.51 - 1.67
Send
sign up or login to leave a comment!
When Written:
1.56
Cortexyme Inc is a clinical-stage biopharmaceutical company that focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. The company's lead drug candidate, COR388, targets the toxic protease produced by the bacteria Porphyromonas gingivalis, which has been linked to Alzheimer's disease. Cortexyme's approach is based on the hypothesis that the bacterial infection triggers inflammation and neurodegeneration, leading to cognitive decline. The company was founded in 2012 and is headquartered in South San Francisco, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








